Home / Centerstage / 2015 / February / Week 1 /
American pharmaceutical company Pfizer reveals its plan to acquire Hospira for $17 billion. Hospira, a global pharmaceutical and medical device company, specializes in the production of generic injectable pharmaceuticals and infusion therapy systems. The acquisition strengthens Pfizer's position in the market and expands its product portfolio, particularly in the areas of acute-care, oncology injectables, and medication management systems.
Wednesday, 4 February, 2015